Marotta Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Marotta Asset Management's IBB Position: Q3 2026 in Review
Marotta Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 0.79% in Q3 2026, selling an estimated $4.21K and leaving 2,628 shares worth $553K. The position accounts for 0.09% of the portfolio, ranked #61.
Marotta Asset Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. 637 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Marotta Asset Management held 2,628 shares of iShares Biotechnology ETF worth $553K as of Q3 2026.
- Marotta Asset Management sold 21 iShares Biotechnology ETF shares in Q3 2026, an estimated $4.21K.
- iShares Biotechnology ETF made up 0.09% of Marotta Asset Management's portfolio in Q3 2026, its #61 holding.
- Marotta Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
- 637 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Marotta Asset Management's 13F filing for Q3 2026, filed 2 Oct 2026.